TearLab Corporation to Release Q2 2014 Financial Results on August 7, 2014
16 Juillet 2014 - 11:30PM
TearLab Corporation (Nasdaq:TEAR) (TSX:TLB) expects to announce its
Q2 2014 financial results after market closes on Thursday, August
7, 2014. TearLab is pleased to invite all willing participants in a
conference call during which time financial results will be
discussed. That call will be held at 4:30pm Eastern at
877-303-1593.
Date: August 7, 2014 Time: 4:30 PM ET
Listen via Internet: http://www.tearlab.com/investor/
Schedule this webcast into MS-Outlook calendar (click open when
prompted):
http://apps.shareholder.com/PNWOutlook/t.aspx?m=65413&k=2C51A457
Telephone: 877-303-1593
For those willing to listen to a recording of the call via
telephone, a replay will be made available by 7:30pm Eastern after
the conclusion of the live call and will remain posted until
11:59pm Eastern on August 13, 2014. To listen to the recording,
simply telephone 855-859-2056 or 800-585-8367 (toll free) or
404-537-3406 and enter conference ID 75504554 when prompted.
About TearLab Corporation: TearLab Corporation (www.tearlab.com)
develops and commercializes lab-on-a-chip technologies that enable
eye care practitioners to improve standard of care by objectively
and quantitatively testing for disease markers in tears at the
point-of-care. The TearLab(R) Osmolarity Test, that enables eye
care practitioners to test for highly sensitive and specific
biomarkers using nanoliters of tear film at the point-of-care, is
the first assay developed for the award winning TearLab Osmolarity
System. Headquartered in San Diego, CA, TearLab Corporation's
common shares trade on the NASDAQ Capital Market under the symbol
'TEAR' and on the Toronto Stock Exchange under the symbol
'TLB'.
Forward-Looking Statements: This press release may contain
forward-looking statements. These statements relate to future
events and are subject to risks, uncertainties and assumptions
about TearLab. Examples of forward-looking statements in this press
release include statements regarding the future potential of the
TearLab Osmolarity System and the related impact on our sales.
These statements are only predictions based on our current
expectations and projections about future events. You should not
place undue reliance on these statements. Actual events or results
may differ materially. Many factors may cause our actual results to
differ materially from any forward-looking statement, including the
factors detailed in our filings with the Securities and Exchange
Commission and Canadian securities regulatory authorities,
including but not limited to our annual and quarterly reports on
Forms 10-K and 10-Q. We do not undertake to update any
forward-looking statements.
CONTACT: Kilmer Lucas Inc.
Stephen Kilmer (President)
647-872-4849
stephen@kilmerlucas.com
Talbots (NYSE:TLB)
Graphique Historique de l'Action
De Nov 2024 à Déc 2024
Talbots (NYSE:TLB)
Graphique Historique de l'Action
De Déc 2023 à Déc 2024
Real-Time news about Talbots (The) (New York Stock Exchange): 0 recent articles
Plus d'articles sur